Stroke experts from UCSF Health presented new research and clinical findings at the annual the American Stroke Association’s International Stroke Conference (ISC25), the world’s premier meeting ...

China: A recent study published in the Journal of Stroke and Cerebrovascular Diseases has highlighted the potential of ...

Removing a clot blocking a medium- or small-sized artery in the brain mechanically is a safe treatment for a common type of ...

Injecting tenecteplase into the artery after clot removal helps improve recovery in stroke survivors by enhancing blood flow ...

A common blood pressure medication used to prevent migraines may also significantly reduce the risk of ischemic stroke in women, according to a new study. The research, presented at the American ...

Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery resulted in stroke survivors being more likely to have better function 90 days ...

The clot-dissolving medication, alteplase, improved stroke patients' recovery by more than 50% when given up to 24 hours after the beginning of an ischemic stroke, according to preliminary ...

In a randomized clinical trial in China, giving the clot-busting medication alteplase up to 24 hours after stroke symptoms ...

Risk for incident stroke and transient ischemic attack, as well as major bleeding ... fibrillation and have important clinical implications for the counseling and management of patients with ...

Mechanically retrieving a blood clot blocking a medium- or small-sized brain artery was no better at reducing disability 90 ...

Chinese clinical scientist Wang Yongjun has been granted the William M. Feinberg Award for Excellence in Clinical Stroke at the 2025 International ...